PressJuly 29, 2021 Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
PressJuly 27, 2021 Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP
PressJuly 26, 2021 Awakn Life Sciences Commences Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’
PressJuly 23, 2021 Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP”
PressJuly 21, 2021 Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States
PressJuly 20, 2021 Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol “LVT”.
PressJuly 19, 2021 Knowde Group Inc. Enters Into a Strategic Partnership with LMC Manna Research to Drive Quality and Collaboration in the Conduct of Cannabis and Psychedelic Clinical Trials.
PressJuly 15, 2021 Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc
PressJuly 15, 2021 Awakn Life Sciences Initiates Research Program to Further Develop Ketamine-Assisted Therapies for Treating Addiction
PressJuly 14, 2021 Clearmind Announces Changes To Senior Management As It Accelerates Development Of Its IP Portfolio
PressJuly 14, 2021 Red Light Holland Sells ~350,000 Grams of Magic Truffles and Increases Points of Sale for iMicrodose Packs
PressJuly 6, 2021 Seelos Therapeutics Doses First Patient in a Study of Intranasal Ketamine for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder
PressJuly 5, 2021 Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
